Related Experiment Video
Updated: Jul 3, 2026
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Comparison of Cannulation Strategies for Minimally Invasive Mitral Valve Surgery.
Juri Sromicki1,2, Nestoras Papadopoulos1,2, Lisa Tröbinger1,2
1Department of Cardiac Surgery, University Hospital Zurich, Zürich, Switzerland.
Summary
Central ascending aortic cannulation (AC) showed fewer complications and less delirium in minimally invasive mitral valve surgery (MIV-MVS) compared to femoral cannulation (FC). Outcomes like 30-day mortality or stroke were similar across strategies.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Minimally Invasive Surgery
Background:
- Minimally invasive mitral valve surgery (MIV-MVS) techniques are advancing.
- Arterial cannulation strategy is a key factor in perioperative management.
- Evaluating different cannulation methods is crucial for optimizing MIV-MVS outcomes.
Purpose of the Study:
- To assess the association between arterial cannulation strategies and perioperative adverse events in MIV-MVS.
- To compare the safety and efficacy of central ascending aortic cannulation (AC) versus femoral cannulation (FC).
- To identify differences in complication rates and postoperative delirium among cannulation techniques.
Main Methods:
- Retrospective analysis of 823 patients undergoing MIV-MVS between 2013 and 2020.
- Comparison of three arterial cannulation methods: AC, open femoral cannulation (oFC), and percutaneous femoral cannulation (pFC).
- Assessment of composite endpoints including 30-day mortality/stroke, all-cause death/stroke/cannulation-related events, and postoperative delirium.
Main Results:
- 30-day mortality or stroke rates were similar across AC and FC groups (2.3%).
- AC was associated with significantly fewer cannulation-related complications and access-site issues compared to FC.
- Patients undergoing AC experienced lower rates of perioperative delirium than those undergoing FC.
Conclusions:
- Arterial cannulation strategy impacts perioperative outcomes in MIV-MVS.
- Central ascending aortic cannulation offers advantages over femoral cannulation regarding complication rates and delirium.
- Further prospective studies are needed to validate these findings.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.